Chikungunya Virus IgA Antibody, Serum
This test detects antibodies specific to the chikungunya virus in your blood serum. It helps identify if your immune system has ever been exposed to the virus, which can cause severe joint pain and other symptoms after infection.
["This test may be used to diagnose past chikungunya virus exposure, especially in cases where symptoms persist or recur."]
Key facts at a glance
- LOINC
- 95705-0
- Short code
- CHIKV-IgA
- Synonyms
- CHIKV IgA Spec Ql IA
- Category
- chemistry
- Sample
- serum
- Container
- Serum separator tube (SST) or red-top vacutainer tube; alternatively, serum collected in sterile cryovial for transport
- Units
- N/A
- Ref low
- 7
- Ref high
- 14
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Enzyme-linked immunosorbent assay (ELISA) or chemiluminescent immunoassay (CLIA) for qualitative detection of IgA antibodies against Chikungunya virus
- CPT
- 86790
- SNOMED
- 122445000
- Specimen volume
- 1-2 mL of serum (minimum 0.5 mL); 3-5 mL whole blood collected in SST
- Stability
- Serum stable at room temperature (15-25°C) for 8 hours; refrigerated (2-8°C) for 7 days; frozen (-20°C or lower) for up to 30 days. Avoid repeated freeze-thaw cycles. Hemolyzed or lipemic samples may yield inaccurate results.
- Hemolysis max
- 200
- Lipemia max
- 100
- Icterus max
- 50
- TAT
- 24–72 hours
- Order
- routine
What Does This Test Measure?
The test measures IgA antibodies, a type of immune protein produced by your body in response to a chikungunya virus infection. IgA antibodies are part of your immune system’s defense and can appear after the virus has cleared but may linger for months or years.
Why Might You Need This Test?
Healthcare providers may order this test if you have symptoms of chikungunya (such as persistent joint pain, fever, or rash) and recent travel to areas where chikungunya is common. It can also help confirm a diagnosis if other tests are inconclusive or if symptoms are unclear.
How Is the Test Performed?
A blood sample is drawn from a vein in your arm. The serum portion of the blood is then tested in a laboratory using an immunoassay method to detect chikungunya-specific IgA antibodies.
What Are Possible Results?
A positive result indicates the presence of IgA antibodies, suggesting past exposure to the chikungunya virus. A negative result means no detectable antibodies were found at the time of testing, which may or may not mean you were never exposed.
Reference range
Negative: No IgA antibodies detected. Positive: IgA antibodies detected, indicating recent or acute Chikungunya virus infection. Equivocal/Borderline: Result indeterminate; recommend repeat testing in 7-14 days.N/A
No special preparation required. Patients do not need to fast before sample collection. Patients should inform their healthcare provider of any recent travel to endemic areas (tropical/subtropical regions) and any vaccination history, as this information aids in result interpretation.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Short name
IgA Antibody to Chikungunya Virus
Frequently asked questions
What Does a Positive Result Mean?
What Does a Negative Result Mean?
How Long Do IgA Antibodies Last?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 15, 2026. · Read our editorial policy